Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
When priorities drift, budgets fray and goals slip away. This intro shows how aligning spending with goals reduces chaos and builds stability.
22,744 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
A leading investment fund recently opened a sizable stake in STGW after marquee client wins. Here’s what this move co...
Investors who missed CrowdStrike’s rally found a diversified path higher, as a cybersecurity ETF posted 29% gains ove...
Choosing between VEA and NZAC boils down to your priority: broad diversification in developed markets or a climate-al...
A federal judge paused the $81 billion Paramount-Warner merger for two weeks as 12 states challenge the deal over com...
Microsoft steps into a Texas data center project abandoned by OpenAI, reshaping AI infrastructure near Abilene as the...
Eli Lilly dominates the GLP-1 space, but competition is heating up from outside and inside its own lineup. This guide...
Investors are watching amplitech (ampg) for clues about growth, margins, and 2026 strategy. This article breaks down ...
Home Depot's Q1 2026 results provide a window into consumer demand, mix shifts, and profitability. This article break...
The leader of america’s largest social security advisory firm argues that the Trump-era tax cuts failed to shore up S...
Snapdocs has named Jamie Mottern as vice president of lender growth, tasking her with expanding digital closings and ...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...